A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report - Chai, Jingjing; Lv, Jiaqi; Xiong, Jian; Chen, Xiuwen; Luo, Senyuan; Luo, Zhiguo; Luo, Ming (Frontiers in Immunology, 2025)